跳至主要内容
临床试验/NCT07580937
NCT07580937已完成不适用

Safety and Efficacy of Left Atrial Ablation After Percutaneous Left Atrial Appendage Occlusion in High-Bleeding-Risk Patients With Atrial Fibrillation: PROCEED-AF Ablation Registry

University of Chicago20 个研究点 分布在 9 个国家目标入组 198 人开始时间: 2022年3月8日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
198
试验地点
20

研究概览

简要总结

The purpose of this multicenter study is to collect information from routine clinical practices for patients with left atrial appendage occlusion (LAAO) devices presenting for pulmonary vein isolation (PVI) or left atrial ablation. Assessment will include characterization of patient characteristics, procedural details, management of post-procedure anticoagulation, and clinical outcomes.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Individuals aged >18 years
  • Undergoing any type of atrial fibrillation ablation or left atrial arrhythmia ablation

排除标准

  • Missing essential baseline characteristics and/or missing collection of sufficient details regarding each complication

研究者

申办方类型
Other
责任方
Sponsor

研究点 (20)

Loading locations...

相似试验